New research paves the way for a new schizophrenia treatment, by testing the effect of a cannabis compound on rats.
The study suggests that the cannabis-derived substance may improve schizophrenia-specific cognitive impairment, with none of the side effects that current medication has.
A new study shows how cannabis-derived CBD can improve schizophrenia-like symptoms in rats.
Schizophrenia affects about 1.1 percent of the American population - or approximately 3.5 million adults.
Click here to read the complete article
Ana Sandoiu ~ MedicalNewsToday.com ~
